Related Experiment Video
Updated: Jul 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Cyclooxygenase-2 expression during immortalization and breast cancer progression
Xiangshan Zhao1, Monica Goswami, Nidhi Pokhriyal
1Division of Cancer Biology, Department of Medicine, Evanston Northwestern Healthcare Research Institute and Feinberg School of Medicine, Evanston, IL, USA.
Cyclooxygenase 2 (COX-2) is not a reliable marker for identifying breast cancer precursor cells. Its expression decreases during tumor progression and does not impact cell growth or oncogenic behavior.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Identifying molecular changes in premalignant human mammary epithelial cells (hMEC) is crucial for understanding breast cancer development.
- Previous research suggested cyclooxygenase 2 (COX-2) expression could mark precursor cells for breast cancer.
Purpose of the Study:
- To investigate the role of COX-2 expression in breast cancer precursor cells and its association with tumor progression.
- To determine if COX-2 expression influences the transformation and oncogenic behavior of hMEC.
Main Methods:
- Analyzed COX-2 expression in preselection and postselection hMEC, immortalized cells, breast cancer cell lines, and clinical specimens.
- Utilized small interfering RNA to down-regulate COX-2 in cells.
- Assessed the impact of COX-2 down-regulation on cell proliferation, anchorage-independent growth, migration, and invasion.
Main Results:
- COX-2 levels were similar in preselection and postselection hMEC but decreased significantly upon immortalization.
- Breast cancer cell lines and tumor specimens exhibited lower COX-2 expression compared to normal hMEC.
- Down-regulating COX-2 did not affect hMEC proliferation, growth, migration, or invasion.
Conclusions:
- COX-2 overexpression does not appear to identify breast cancer precursor cells or confer a transformation advantage.
- COX-2 inhibition does not impact hMEC growth or oncogenic potential under the studied conditions.
- COX-2 expression is downregulated during breast cancer progression from normal epithelial cells to invasive carcinoma.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Inhibition of Cdk Activity